Reducing the Cost of Private Sector Antiretrovirals in Namibia

A Means to Increase Access

This presentation discusses a SHOPS study in Namibia that collected and analyzed data regarding the characteristics of the market for antiretroviral (ARV) treatments in Namibia. The study found that medicines in the private sector are more expensive, and the public sector tends to prescribe cheaper, generic drugs. The authors believe that if the private health sector could provide its patients with the low-cost, generic drugs as in the public sector, it would greatly increase Namibian's access to ARVs. This presentation was given by Ilana Ron Levey on July 6, 2013 at the pre-iHEA Private Sector in Health Symposium in Sydney, Austrailia.

Author

Dineo Dawn Pereko, Els Sweeney-Bindels, Rich Feeley, Ilana Ron Levey, Ingrid de Beer, Thierry Uwamahoro, Etienne Coetzee and Jennie Lates

Contributor

SHOPS Project

Published
July 2013
Resource Types
Presentation
Country
Namibia
Health Area
HIV
Keywords
HIV/AIDS
health products
antiretroviral treatment
AIDS
Current Downloads
7

shops-logo.png

usaid-logo-color.png

Sustaining Health Outcomes through the Private Sector (SHOPS) Plus is a five-year cooperative agreement (AID-OAA-A-15-00067) funded by the United States Agency for International Development (USAID). This website is made possible by the generous support of the American people through USAID. The information provided on this website is not official U.S. government information and does not represent the views or positions of USAID or the U.S. government.

Sign-up for our newsletter to get the latest updates from SHOPS Plus